BIOC logo

GlaxoSmithKline S.A.E Stock Price

CASE:BIOC Community·ج.م5.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

BIOC Share Price Performance

ج.م70.98
31.61 (80.29%)
ج.م70.98
31.61 (80.29%)
Price ج.م70.98

BIOC Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with questionable track record.

1 Risk
1 Reward

GlaxoSmithKline S.A.E Key Details

ج.م3.7b

Revenue

ج.م3.1b

Cost of Revenue

ج.م679.8m

Gross Profit

ج.م466.5m

Other Expenses

ج.م213.2m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
2.55
18.22%
5.72%
0%
View Full Analysis

About BIOC

Founded
1981
Employees
n/a
CEO
Heba El Morshedy
WebsiteView website
www.gsk.com/en-gb/contact-us/worldwide/egypt

GlaxoSmithKline S.A.E engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E was founded in 1981 and is based in New Cairo, Egypt. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

Recent BIOC News & Updates

Recent updates

No updates

GlaxoSmithKline S.A.E Competitors